Fungal infections in Algeria

Aissat, Fatma Zohra; Denning, David W.

doi:10.1111/myc.13585

Cited by 3 publications

(2 citation statements)

References 37 publications

(68 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The lack of mycology laboratories and expertise in many LMICs has also led to low awareness of fungal diseases among health care professionals (HCPs) [ 34–38 ]. The overall incidence of health care–associated infections, such as candidemia, is considerably high in many middle-income countries, likely reflecting incomplete infection control efforts, excess antifungal use, and few stewardship programs [ 38 ].…”

Section: Methodsmentioning

confidence: 99%

The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective

Arendrup,

Armstrong-James,

Borman

et al. 2024

Open Forum Infectious Diseases

View full text Add to dashboard Cite

Fungal diseases represent a considerable global health concern, affecting over one billion people annually. In response to this growing challenge, the World Health Organization introduced the pivotal fungal priority pathogens list (FPPL) in late 2022. The FPPL highlights the challenges in estimating the global burden of fungal diseases and antifungal resistance (AFR), as well as limited surveillance capabilities and lack of routine AFR testing. Furthermore, training programmes should incorporate sufficient information on fungal diseases, necessitating global advocacy to educate healthcare professionals and scientists. Established international guidelines and the FPPL are vital in strengthening local guidance on tackling fungal diseases. Future iterations of the FPPL have the potential to refine the list further, addressing its limitations and advancing our collective ability to combat fungal diseases effectively. Napp Pharmaceuticals Limited (Mundipharma UK) organised a workshop with key experts from Northern Europe to discuss the impact the FPPL will have on regional clinical practice.

show abstract

Section: Methodsmentioning

confidence: 99%

The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective

Arendrup,

Armstrong-James,

Borman

et al. 2024

Open Forum Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…Cryptococcal meningitis is uncommon in the Middle East, estimated at 1.2% [68], so probably two cases annually. We assume another six cases in non-HIV patients, based on other country data [69]. Pneumocystis pneumonia (PCP) is more common, at 15.1% in Bahrain [42], so probably 15 HIV-related cases annually (Table 3).…”

Section: Invasive Fungal Infections Associated With Hivmentioning

confidence: 99%

Mapping the Burden of Fungal Diseases in the United Arab Emirates

Al Dhaheri,

Thomsen,

Everett

et al. 2024

JoF

Self Cite

View full text Add to dashboard Cite

The United Arab Emirates has very little data on the incidence or prevalence of fungal diseases. Using total and underlying disease risk populations and likely affected proportions, we have modelled the burden of fungal disease for the first time. The most prevalent serious fungal conditions are recurrent vulvovaginitis (~190,000 affected) and fungal asthma (~34,000 affected). Given the UAE’s low prevalence of HIV, we estimate an at-risk population of 204 with respect to serious fungal infections with cryptococcal meningitis estimated at 2 cases annually, 15 cases of Pneumocystis pneumonia (PCP) annually, and 20 cases of esophageal candidiasis in the HIV population. PCP incidence in non-HIV patients is estimated at 150 cases annually. Likewise, with the same low prevalence of tuberculosis in the country, we estimate a total chronic pulmonary aspergillosis prevalence of 1002 cases. The estimated annual incidence of invasive aspergillosis is 505 patients, based on local data on rates of malignancy, solid organ transplantation, and chronic obstructive pulmonary disease (5.9 per 100,000). Based on the 2022 annual report of the UAE’s national surveillance database, candidaemia annual incidence is 1090 (11.8/100,000), of which 49.2% occurs in intensive care. Fungal diseases affect ~228,695 (2.46%) of the population in the UAE.

show abstract

Diagnostic capacity for cutaneous fungal diseases in the African continent

Badiane,

Ramarozatovo,

Doumbo

et al. 2023

Int J Dermatology

Self Cite

View full text Add to dashboard Cite

BackgroundCutaneous fungal infections are very common, especially in poorer communities and with intercurrent HIV infection. Determining the fungal pathogen in skin‐related fungal neglected tropical diseases (NTDs) determines optimal therapy. We undertook a country survey across many African countries to determine the diagnostic capacity for skin fungal diseases.MethodsA detailed questionnaire was delivered to country contacts to collect data on availability, frequency, and location of testing for key diagnostic procedures and followed up with 2 rounds of validation by video call and by confirmation of individual country data confirmation by email.ResultsOf 47 countries with data, seven (15%) and 21 (45%) do not offer skin biopsy in the public or private sector, respectively, but 22 (46%) countries do it regularly, mostly in university hospitals. Direct microscopy is often performed in 20 of 48 (42%) countries in the public sector and not done in 10 (21%). Fungal cultures are often performed in 21 of 48 (44%) countries in the public sector but not done in nine (20%) or 21 (44%) in either public or private facilities. Histopathological examination of tissue is frequently used in 19 of 48 (40%) countries but not in nine (20%) countries in the public sector. The cost of diagnostics to patients was a major limiting factor in usage.ConclusionMajor improvements in the availability and use of diagnostic tests for skin, hair, and nail fungal disease are urgently needed across Africa.

show abstract

Fungal infections in Algeria

Cited by 3 publications

References 37 publications

The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective

The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective

Mapping the Burden of Fungal Diseases in the United Arab Emirates

Diagnostic capacity for cutaneous fungal diseases in the African continent

Contact Info

Product

Resources

About